ALPN Stock Report: Alpine Immune Sciences Shines with Strong Q4 2023 Performances

Updated On: March 18, 2024 10:48 pm

ALPN stock - ALPN Stock Report: Alpine Immune Sciences Shines with Strong Q4 2023 Performances

Source: iQoncept / Shutterstock

Alpine Immune Sciences (NASDAQ:ALPN) has left analysts awe-struck with its fourth-quarter 2023 financial results.

Reporting a substantial earnings per share of 15 cents, Alpine Immune Sciences startled the market, surpassing the projected EPS of -34 cents.
The company’s revenue of $30.85 million has sent ripples through the industry, boasting a staggering 239.04% beat compared to the anticipated revenue of $9.10 million.

InvestorPlace Earnings has automated the analysis of quarterly earnings using TradeSmith data, providing investors with comprehensive insights like EPS and revenue figures. These reports are driven by data to deliver the latest financial updates efficiently. For any feedback or corrections, reach us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/alpn-stock-earnings-alpine-immune-sciences-for-q4-of-2023/.